Health ❯Healthcare ❯Clinical Research

Patient Studies

COVID-19 and Obesity Cardiovascular Events

Novo Nordisk's Oral Semaglutide Shows 14% Reduction in Heart Risks

New Studies Confirm Safety of Semaglutide for Mental Health